A comparison of Dysport (100 U/ml) and Botox (100 U/ml) using dose conversion factor 3:1 and 1.7:1 in the treatment of cervical dystonia.
Phase of Trial: Phase IV
Latest Information Update: 11 Sep 2015
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Torticollis
- Focus Therapeutic Use
- Acronyms DysBot
- 11 Sep 2015 Results published in the Clinical Neuropharmacology.
- 12 Jul 2011 New trial record